Press Release
Category Added in a WPeMatico Campaign
-
SWEP Expands Heat Transfer Offering Through New Strategic Partnership
DOWNERS GROVE, Ill., April 21, 2026 /PRNewswire/ — SWEP, part of Dover (NYSE: DOV) and a world-leading supplier of brazed…
Read More » -
Johnson Controls Announces Second Quarter 2026 Earnings Conference Call Webcast and “Going to Gemba Day” for Investors and Sell-Side Analysts
CORK, Ireland, April 21, 2026 /PRNewswire/ — Johnson Controls International plc (NYSE: JCI), a global technology leader in energy efficiency,…
Read More » -
BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase
Award Recognizes Technologies That Address Important Industry Needs and Advance Prior Standards BOTHELL, Wash., April 21, 2026 /PRNewswire/ — BioLife Solutions,…
Read More » -
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026
DUBLIN, April 21, 2026 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced it will report its 2026 first quarter…
Read More » -
Jazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)
Rapid oral presentation of PD-L1 subgroup data from HERIZON-GEA-01 evaluating zanidatamab combinations, and additional analyses of tolerability, biomarker response and…
Read More » -
Resideo To Release First Quarter 2026 Financial Results on May 12, 2026
SCOTTSDALE, Ariz., April 21, 2026 /PRNewswire/ — Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of…
Read More » -
Inhibrx Provides Clinical Update on Ozekibart (INBRX-109) in Late Line Colorectal Cancer
SAN DIEGO, April 21, 2026 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a clinical-stage biopharmaceutical company…
Read More » -
ISCT Announces Inaugural CGT Clinical Applications Program for Clinical Fellows
VANCOUVER, BC, April 21, 2026 /PRNewswire/ – The International Society for Cell & Gene Therapy (ISCT) Institute of Training & Development…
Read More » -
Health In Tech to Present at the Market Movers Investor Summit
STUART, Fla., April 21, 2026 /PRNewswire/ — Health In Tech, Inc. (Nasdaq: HIT) (the “Company”), an AI-enabled InsurTech platform company,…
Read More » -
NeoCognition Emerges from Stealth With $40 Million Seed Round to Advance Specialized Intelligence and Expert Agents
Founded by the research team behind one of the most established AI agent labs in the country, NeoCognition aims to…
Read More »
